FDA accelerates drug approval for patients with aggressive breast cancersThe Breast Cancer Site
By Robin Wulffson MD for eMaxHealth.com
New Food and Drug Administration (FDA) guidelines were released this week that grant accelerated approval of new drugs for use in women with aggressive, early-stage breast cancers. The approval was granted in the hope that their use might give them the best chance for a cure drug.
The decision will allow pharmaceutical manufacturers to test the drugs on a few months before they undergo breast cancer surgery, instead of waiting until the medication has been proven first in seriously ill patients. The FDA is accepting comments about its draft plan through the end of July.